Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New treatment options in advanced squamous cell lung cancer
    Review

    Paik, P. K.; Pillai, R. N.; Lathan, C. S.; Velasco, S. A.; Papadimitrakopoulou, V.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours
    Meeting Abstract

    Ziegler, D. S.; Doz, F.; Geoerger, B.; Dubois, S.; Grilley-Olson, J. E.; van Tilburg, C.; Italiano, A.; Lissat, A.; Kang, J. H.; Tahara, M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis
    Meeting Abstract

    Paz-Ares, L.; Ciuleanu, T. E.; Yu, X.; Salman, P.; Pluzanski, A.; Nagrial, A.; Havel, L.; Kowalyszyn, R.; Audigier-Valette, C.; Wu, Y. L.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Pooled safety analysis of tepotinib in Asian patients with advanced solid tumours
    Meeting Abstract

    Yamazaki, K.; Ryoo, B. Y.; Doi, T.; Paik, P. K.; Veillon, R.; Decaens, T.; Faivre, S.; Falchook, G. S.; Hong, D. S.; Scheele, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI
    Meeting Abstract

    Han, J. Y.; Sequist, L. V.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
    Meeting Abstract

    Hyman, D.; Tan, D. S. W.; van Tilburg, C.; Albert, C.; Geoerger, B.; Farago, A.; Laetsch, T.; Kummar, S.; Doz, F.; Lassen, U.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study
    Meeting Abstract

    Park, K.; Felip, E.; Veillon, R.; Cortot, A.; Mazieres, J.; Sakai, H.; Reinmuth, N.; Viteri, S.; Chen, Y. M.; Han, J. Y.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
    Meeting Abstract

    de Braud, F.; Siena, S.; Barlesi, F.; Drilon, A.; Simmons, B.; Huang, X.; Osborne, S.; Doebele, R. C.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Paz-Ares, L.; Caro, R. B.; Zurawski, B.; Kim, S. W.; Costa, E. C.; Park, K.; Alexandru, A.; Lupinacci, L.; de la Mora Jimenez, E.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines
    Guidelines

    Ettinger, D. S.; Wood, D. E.; Aggarwal, C.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save